Cancer Cell‐Specific Fluorescent Prodrug Delivery Platforms
暂无分享,去创建一个
G. Chen | Ji Hyeon Kim | Lu Li | Bo Tang | Jong Seung Kim | Yuxia Liu | Wei Tao | Wei Chen | Jieun Lee | Siyue Ma | Junlian Xue
[1] S. Gómez‐Ruiz,et al. Synthesis of a theranostic platform based on fibrous silica nanoparticles for the enhanced treatment of triple-negative breast cancer promoted by a combination of chemotherapeutic agents. , 2022, Biomaterials advances.
[2] Dustin A Cobb,et al. Targeting of the alphav beta3 integrin complex by CAR-T cells leads to rapid regression of diffuse intrinsic pontine glioma and glioblastoma , 2022, Journal for ImmunoTherapy of Cancer.
[3] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[4] I. Pashkuleva,et al. Influence of Hyaluronan Density on the Behavior of Breast Cancer Cells with Different CD44 Expression , 2021, Advanced healthcare materials.
[5] Hongyan Zhu,et al. Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy. , 2021, Carbohydrate polymers.
[6] J. Sessler,et al. A Small Molecule Strategy for Targeting Cancer Stem Cells in Hypoxic Microenvironments and Preventing Tumorigenesis. , 2021, Journal of the American Chemical Society.
[7] Jun-fang Gao,et al. Construction of a biotin-targeting drug delivery system and its near-infrared theranostic fluorescent probe for real-time image-guided therapy of lung cancer , 2021, Chinese Chemical Letters.
[8] Hong-Wei Sun,et al. Near infrared light fluorescence imaging-guided biomimetic nanoparticles of extracellular vesicles deliver indocyanine green and paclitaxel for hyperthermia combined with chemotherapy against glioma , 2021, Journal of Nanobiotechnology.
[9] A. Yodh,et al. NIR Fluorescent Imaging and Photodynamic Therapy with a Novel Theranostic Phospholipid Probe for Triple-Negative Breast Cancer Cells. , 2021, Bioconjugate chemistry.
[10] Y. Xiong,et al. Advancing targeted protein degradation for cancer therapy , 2021, Nature Reviews Cancer.
[11] T. James,et al. Dual-locked spectroscopic probes for sensing and therapy , 2021, Nature Reviews Chemistry.
[12] Zhiai Xu,et al. Nitric Oxide Prodrug Delivery and Release Monitoring Based on a Galactose-Modified Multifunctional Nanoprobe. , 2021, Analytical chemistry.
[13] S. Bates,et al. Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance , 2021, Nature Communications.
[14] C. Curti,et al. RGD Peptide‐Drug Conjugates as Effective Dual Targeting Platforms: Recent Advances , 2021 .
[15] U. Khoo,et al. Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer , 2021, Cancers.
[16] Yihan Wu,et al. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core–shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis , 2021, Journal of Nanobiotechnology.
[17] C. Bertozzi,et al. LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation , 2021, Nature Chemical Biology.
[18] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[19] Xiaofei Liang,et al. Protein liposomes-mediated targeted acetylcholinesterase gene delivery for effective liver cancer therapy , 2021, Journal of Nanobiotechnology.
[20] X. Shuai,et al. Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma , 2020, Advanced science.
[21] Xuan Zhu,et al. Self-Distinguishing and Stimulus-Responsive Carrier-Free Theranostic Nanoagents for Imaging-Guided Chemo-Photothermal Therapy in Small-Cell Lung Cancer. , 2020, ACS applied materials & interfaces.
[22] Wukun Liu,et al. Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer. , 2020, Journal of medicinal chemistry.
[23] H. Tian,et al. Real-Time Visual Monitoring of Kinetically Controlled Self-Assembly. , 2020, Angewandte Chemie.
[24] Feng Li,et al. Label-free homogeneous electrochemical detection of MicroRNA based on target-induced anti-shielding against the catalytic activity of two-dimension nanozyme. , 2020, Biosensors & bioelectronics.
[25] Jian Zhang,et al. SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo. , 2020, Colloids and surfaces. B, Biointerfaces.
[26] Yuan Luo,et al. Small Molecular Prodrug Amphiphile Self-Assembled AIE Dots for Cancer Theranostics , 2020, Frontiers in Bioengineering and Biotechnology.
[27] Meihua Qu,et al. Enhanced targeted delivery of adenine to hepatocellular carcinoma using glycyrrhetinic acid-functionalized nanoparticles in vivo and in vitro. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[28] Fang Zeng,et al. An Activatable Nano-Prodrug for Treating Tyrosine-Kinase-Inhibitor-Resistant Non-Small Cell Lung Cancer and for Optoacoustic and Fluorescent Imaging. , 2020, Small.
[29] A. Dennison,et al. Targeted therapy for hepatocellular carcinoma , 2020, Signal Transduction and Targeted Therapy.
[30] Carolyn R. Bertozzi,et al. Lysosome-targeting chimaeras for degradation of extracellular proteins , 2020, Nature.
[31] D. Vignali,et al. Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy , 2020, Journal for ImmunoTherapy of Cancer.
[32] L. Ji,et al. CAIXplatins: highly potent Pt(IV) prodrugs selectively against hypoxic tumors via microenvironment and metabolism regulation. , 2020, Angewandte Chemie.
[33] Jiaheng Zhang,et al. Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy. , 2020, ACS biomaterials science & engineering.
[34] Yan-ping Shi,et al. Precisely Traceable Drug Delivery of Azoreductase-Responsive Prodrug for Colon Targeting via Multimodal Imaging. , 2020, Analytical chemistry.
[35] Lihui Wei,et al. Evaluation of folate receptor‐mediated tumor detection as a triage tool in cervical cancer screening , 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[36] Jianjun Du,et al. A Single Molecule Drug Targeting Photosensitizer for Enhanced Breast Cancer Photothermal Therapy. , 2020, Small.
[37] S. Ghosh,et al. Transferrin-Conjugated Red Blood Cell Membrane-Coated Poly(lactic-co-glycolic acid) Nanoparticles for the Delivery of Doxorubicin and Methylene Blue , 2020 .
[38] Yi-Zhou Wu,et al. From Ancient Medicine to Targeted Nanocarrier: A Sparganii Rhizoma-Derived Nanoparticle for Diagnostic Imaging and Endocrine Therapy in Cancer , 2020 .
[39] Ji Hyeon Kim,et al. Unimolecular Photodynamic O2-Economizer to Overcome Hypoxia Resistance in Phototherapeutics. , 2020, Journal of the American Chemical Society.
[40] Haijun Yu,et al. Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer , 2020, Advanced science.
[41] A. Zelikin,et al. Molecular, macromolecular, and supramolecular glucuronide prodrugs: an unexpected lead identified for anticancer prodrug monotherapy. , 2020, Angewandte Chemie.
[42] B. Kent,et al. Estrone decorated poly-ion complex micelles for targeted melittin delivery to hormone responsive breast cancer cells. , 2020, Biomacromolecules.
[43] Shriti Singh,et al. Challenges in liver cancer and possible treatment approaches. , 2020, Biochimica et biophysica acta. Reviews on cancer.
[44] K. Cai,et al. An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy. , 2019, Biomaterials.
[45] C. Frochot,et al. New Targeted Gold Nanorods for the Treatment of Glioblastoma by Photodynamic Therapy , 2019, Journal of clinical medicine.
[46] Rahul Gupta,et al. Hyaluronic Acid-Tacrolimus Bioconjugate: Synthesis, Characterization, and Pharmacokinetic Investigation of an Acid-Responsive Macromolecular Prodrug. , 2019, ACS applied bio materials.
[47] S. Singh,et al. Estrogen signaling: An emanating therapeutic target for breast cancer treatment. , 2019, European journal of medicinal chemistry.
[48] Shengke Li,et al. Host-Guest Interactions Initiated Supramolecular Chitosan Nanogels for Selective Intracellular Drug Delivery. , 2019, ACS applied materials & interfaces.
[49] G. Storm,et al. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo. , 2019, Acta biomaterialia.
[50] L. Mancini,et al. Drug-Initiated Synthesis of Heterotelechelic Polymer Prodrug Nanoparticles for in Vivo Imaging and Cancer Cell Targeting. , 2019, Biomacromolecules.
[51] Rami W. Chakroun,et al. Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering. , 2019, ACS nano.
[52] A. Tedesco,et al. Prodrugs for targeted cancer therapy , 2019, Expert review of anticancer therapy.
[53] Lingdi Zhao,et al. Exploring a Tumor-Intrinsic PD-L1 Signal with Proximity-Dependent Biotin Identification in Lung Cancer Cells. , 2019, Biochemistry.
[54] Yanli Zhao,et al. Light-Responsive Prodrug-Based Supramolecular Nanosystems for Site-Specific Combination Therapy of Cancer , 2019, Chemistry of Materials.
[55] G. Gasser,et al. Polymer encapsulation of ruthenium complexes for biological and medicinal applications , 2019, Nature Reviews Chemistry.
[56] R. Weissleder,et al. Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy. , 2019, ACS nano.
[57] David S. Kittle,et al. Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme. , 2019, Biomaterials.
[58] J. Qu,et al. A pH‐Responsive Glycyrrhetinic‐Acid‐Modified Small‐Molecule Conjugate for NIR Imaging of Hepatocellular Carcinoma (HCC) , 2019, Chembiochem : a European journal of chemical biology.
[59] Feng Li,et al. Nucleic Acid-Functionalized Metal-Organic Framework-Based Homogeneous Electrochemical Biosensor for Simultaneous Detection of Multiple Tumor Biomarkers. , 2019, Analytical chemistry.
[60] P. Chanvorachote,et al. Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer , 2019, AntiCancer Research.
[61] X. Zhang,et al. Designing luminescent ruthenium prodrug for precise cancer therapy and rapid clinical diagnosis. , 2019, Biomaterials.
[62] Zhe Wang,et al. Redox Dual-Responsive and O2‑Evolving Theranostic Nanosystem for Highly Selective Chemotherapy against Hypoxic Tumors , 2019, Theranostics.
[63] U. Rashid,et al. Biomedical Applications of Aromatic Azo Compounds. , 2018, Mini reviews in medicinal chemistry.
[64] T. Mok,et al. Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer , 2018, Current Treatment Options in Oncology.
[65] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[66] Y. Liu,et al. Magnetism and photo dual-controlled supramolecular assembly for suppression of tumor invasion and metastasis , 2018, Science Advances.
[67] Q. Tang,et al. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. , 2018, Biomaterials.
[68] Si‐Yong Qin,et al. Combinational strategy for high-performance cancer chemotherapy. , 2018, Biomaterials.
[69] M. Leite,et al. Design and Development of Polysaccharide-Doxorubicin-Peptide Bioconjugates for Dual Synergistic Effects of Integrin-Targeted and Cell-Penetrating Peptides for Cancer Chemotherapy. , 2018, Bioconjugate chemistry.
[70] Zelin Chen,et al. Tumor Inhibition Achieved by Targeting and Regulating Multiple Key Elements in EGFR Signaling Pathway Using a Self‐Assembled Nanoprodrug , 2018 .
[71] Jun Liu,et al. Towards Improvements for Penetrating the Blood–Brain Barrier—Recent Progress from a Material and Pharmaceutical Perspective , 2018, Cells.
[72] Lingxin Chen,et al. Polyamine-Targeting Gefitinib Prodrug and its Near-Infrared Fluorescent Theranostic Derivative for Monitoring Drug Delivery and Lung Cancer Therapy , 2018, Theranostics.
[73] Haijia Su,et al. CD44-Targeted Facile Enzymatic Activatable Chitosan Nanoparticles for Efficient Antitumor Therapy and Reversal of Multidrug Resistance. , 2018, Biomacromolecules.
[74] Wei He,et al. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells. , 2018, ACS nano.
[75] Haiyang Xie,et al. Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting. , 2018, ACS applied materials & interfaces.
[76] Jian Liu,et al. Theranostic Prodrug Vesicles for Reactive Oxygen Species‐Triggered Ultrafast Drug Release and Local‐Regional Therapy of Metastatic Triple‐Negative Breast Cancer , 2017 .
[77] Mingdong Huang,et al. A Molecular Combination of Zinc(II) Phthalocyanine and Tamoxifen Derivative for Dual Targeting Photodynamic Therapy and Hormone Therapy. , 2017, Journal of medicinal chemistry.
[78] K. Ligon,et al. Glioblastoma targeted therapy: updated approaches from recent biological insights , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[79] Ying-Wei Yang,et al. Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer Therapy , 2017, Advanced materials.
[80] J. Sessler,et al. Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach. , 2017, Journal of the American Chemical Society.
[81] K. Hong,et al. In vivo imaging of β-galactosidase stimulated activity in hepatocellular carcinoma using ligand-targeted fluorescent probe. , 2017, Biomaterials.
[82] Yuejun Kang,et al. Disassembly of amphiphilic small molecular prodrug with fluorescence switch induced by pH and folic acid receptors for targeted delivery and controlled release. , 2017, Colloids and surfaces. B, Biointerfaces.
[83] Steven J. M. Jones,et al. Integrated genomic and molecular characterization of cervical cancer , 2017, Nature.
[84] Jiawang Liu,et al. Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator. , 2017, ACS medicinal chemistry letters.
[85] Xiuzhen Wang,et al. Enhanced Antiglioma Efficacy of Ultrahigh Loading Capacity Paclitaxel Prodrug Conjugate Self-Assembled Targeted Nanoparticles. , 2017, ACS applied materials & interfaces.
[86] B. Tang,et al. Theranostic hyaluronic acid prodrug micelles with aggregation-induced emission characteristics for targeted drug delivery , 2016, Science China Chemistry.
[87] K. Hodivala-Dilke,et al. αvβ3 Integrin and tumour blood vessels-learning from the past to shape the future. , 2016, Current opinion in cell biology.
[88] K. Hong,et al. Hypoxia-directed and activated theranostic agent: Imaging and treatment of solid tumor. , 2016, Biomaterials.
[89] Hui Tan,et al. Investigation of SP94 Peptide as a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy , 2016, Scientific Reports.
[90] Yanli Zhao,et al. Responsive Prodrug Self-Assembled Vesicles for Targeted Chemotherapy in Combination with Intracellular Imaging. , 2016, ACS applied materials & interfaces.
[91] J. Ji,et al. Intracellular Dual Fluorescent Lightup Bioprobes for Image-Guided Photodynamic Cancer Therapy. , 2016, Small.
[92] L. Minutoli,et al. ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies , 2016, International journal of molecular sciences.
[93] Kangqiang Qiu,et al. Long-Term Lysosomes Tracking with a Water-Soluble Two-Photon Phosphorescent Iridium(III) Complex. , 2016, ACS applied materials & interfaces.
[94] Jong Seung Kim,et al. Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy. , 2016, Bioconjugate chemistry.
[95] T. Moos,et al. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[96] Meiwan Chen,et al. Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy. , 2016, Molecular pharmaceutics.
[97] Hua Wu,et al. Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 , 2016, Theranostics.
[98] Xian‐Zheng Zhang,et al. A Dual‐FRET‐Based Versatile Prodrug for Real‐Time Drug Release Monitoring and In Situ Therapeutic Efficacy Evaluation , 2015 .
[99] J. Ji,et al. Biomimic pH/reduction dual-sensitive reversibly cross-linked hyaluronic acid prodrug micelles for targeted intracellular drug delivery , 2015 .
[100] Bin Chen,et al. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy , 2015, Scientific Reports.
[101] Zhirong Zhang,et al. Integrin αvβ3 targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides , 2015, Amino Acids.
[102] Yuanyuan Liu,et al. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma. , 2015, International journal of pharmaceutics.
[103] P. Devarajan,et al. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[104] Xiaodong Xie,et al. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[105] P. Low,et al. Principles in the design of ligand-targeted cancer therapeutics and imaging agents , 2015, Nature Reviews Drug Discovery.
[106] Jong-Hoon Kim,et al. Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and precise cancer treatment. , 2014, Journal of the American Chemical Society.
[107] Debabrata Sen,et al. Ratiometric two-photon fluorescent probe for quantitative detection of β-galactosidase activity in senescent cells. , 2014, Analytical chemistry.
[108] Xiaoling Fang,et al. Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis. , 2014, Biomaterials.
[109] Masayuki Miura,et al. Selective ablation of β-galactosidase-expressing cells with a rationally designed activatable photosensitizer. , 2014, Angewandte Chemie.
[110] Anzar Khan,et al. Enzyme-triggered cascade reactions and assembly of abiotic block copolymers into micellar nanostructures. , 2014, Journal of the American Chemical Society.
[111] Stephanie M. Tortorella,et al. Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy , 2014, The Journal of Membrane Biology.
[112] Ben Zhong Tang,et al. Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. , 2014, Journal of the American Chemical Society.
[113] R. Lutz,et al. Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models , 2014, mAbs.
[114] Trevor J Pugh,et al. Landscape of genomic alterations in cervical carcinomas , 2013, Nature.
[115] Vladimir P Torchilin,et al. Nanopreparations to overcome multidrug resistance in cancer. , 2013, Advanced drug delivery reviews.
[116] Takahiro Nomoto,et al. Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier. , 2013, ACS nano.
[117] Jong Seung Kim,et al. A fluorescence off-on reporter for real time monitoring of gemcitabine delivery to the cancer cells. , 2013, Chemical communications.
[118] B. Gryder,et al. Histone deacetylase inhibitors equipped with estrogen receptor modulation activity. , 2013, Journal of medicinal chemistry.
[119] N. Abbott. Blood–brain barrier structure and function and the challenges for CNS drug delivery , 2013, Journal of Inherited Metabolic Disease.
[120] S. Vinogradov,et al. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. , 2013, Bioconjugate chemistry.
[121] Jae Hong Lee,et al. Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug. , 2013, Journal of the American Chemical Society.
[122] C. Lüder,et al. Apoptosis-like cell death pathways in the unicellular parasite Toxoplasma gondii following treatment with apoptosis inducers and chemotherapeutic agents: a proof-of-concept study , 2013, Apoptosis.
[123] J. Ji,et al. Small and Stable Phosphorylcholine Zwitterionic Quantum Dots for Weak Nonspecific Phagocytosis and Effective Tat Peptide Functionalization , 2013, Advanced healthcare materials.
[124] R. Jenkins,et al. Genetics of adult glioma. , 2012, Cancer genetics.
[125] S. Achilefu,et al. Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy. , 2012, Nanoscale.
[126] J. Prakash,et al. Drug targeting to the diseased liver. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[127] M. Hashizume,et al. Development of human hepatocellular carcinoma cell-targeted protein cages. , 2012, Bioconjugate chemistry.
[128] Jong Seung Kim,et al. Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug. , 2012, Journal of the American Chemical Society.
[129] J. A. Hendricks,et al. Design, synthesis, and initial biological evaluation of a steroidal anti-estrogen-doxorubicin bioconjugate for targeting estrogen receptor-positive breast cancer cells. , 2012, Bioconjugate chemistry.
[130] Min Liu,et al. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. , 2010, Biomaterials.
[131] Ralph Weissleder,et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.
[132] T. Mikkelsen,et al. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway , 2007, Oncogene.
[133] O. Nielsen,et al. Drug Insight: aminosalicylates for the treatment of IBD , 2007, Nature Clinical Practice Gastroenterology &Hepatology.
[134] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[135] H. Sussman,et al. Demonstration of the transferrin receptor in human breast cancer tissue. Potential marker for identifying dividing cells , 1981, International journal of cancer.
[136] L. V. van Bogaert. Breast cancer , 2019, Nature Reviews Disease Primers.
[137] N. Lu,et al. Transferrin-inspired vehicles based on pH-responsive coordination bond to combat multidrug-resistant breast cancer. , 2017, Biomaterials.
[138] David A. Cheresh,et al. Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.
[139] A. Mintz,et al. IL-13Rα2 is a Glioma-Restricted Receptor for Interleukin-13 , 2002 .
[140] K. Goa,et al. Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis. , 2002, Drugs.